Yahoo
    XETRA - Delayed Quote EUR

    Novo Nordisk A/S (NOV.DE)

    35.71 +0.94 (+2.70%)
    At close: October 30 at 5:35:53 PM GMT+1
    Loading Chart for NOV.DE
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Novo Nordisk Trades at 10 Times Earnings While Buying Back Billions in Stock. Is This the Bottom?

    Novo Nordisk Trades at 10 Times Earnings While Buying Back Billions in Stock. Is This the Bottom?
    Motley Fool 6h ago
    Eli Lilly Rallies 11% in a Week as Q3 Sales Jump 39%, “Exceeding Our Prior Expectations”

    Eli Lilly Rallies 11% in a Week as Q3 Sales Jump 39%, “Exceeding Our Prior Expectations”
    TIKR 1d ago
    Eli Lilly Soars 11% in a Week on a $5.5 Billion Guidance Raise: “Beating on the Up”

    Eli Lilly Soars 11% in a Week on a $5.5 Billion Guidance Raise: “Beating on the Up”
    TIKR 1d ago
    Can Novo Nordisk (NYSE:NVO) Trade Below Fair Value On Earnings?

    Can Novo Nordisk (NYSE:NVO) Trade Below Fair Value On Earnings?
    Simply Wall St. 1d ago
    Novo Nordisk (NYSE:NVO) Could Be 61% Undervalued Following Rising GLP 1 Competition

    Novo Nordisk (NYSE:NVO) Could Be 61% Undervalued Following Rising GLP 1 Competition
    Simply Wall St. 1d ago
    Eli Lilly’s Next Trillion-Dollar Opportunity May Go Beyond Weight-Loss Drugs

    Eli Lilly’s Next Trillion-Dollar Opportunity May Go Beyond Weight-Loss Drugs
    24/7 Wall St. 2d ago
    Novo Nordisk (NVO) Sets New 2030 Goals As GLP 1 Competition Builds

    Novo Nordisk (NVO) Sets New 2030 Goals As GLP 1 Competition Builds
    Simply Wall St. 2d ago
    Agios Sinks 18% as FDA Delays Sickle Cell Drug Decision to 2027 Despite Being “Launch-Ready”

    Agios Sinks 18% as FDA Delays Sickle Cell Drug Decision to 2027 Despite Being “Launch-Ready”
    TIKR 2d ago
    Global Weight Loss Market Size, Share, Trends & Forecast (2026-2036) Featuring Novo Nordisk, Boehringer Ingelheim, Herbalife, WW Int'l, Medtronic and More | GLP-1 Drugs, Oral Therapies, Coverage, and Telehealth Propel Market to $244 Billion by 2036

    Global Weight Loss Market Size, Share, Trends & Forecast (2026-2036) Featuring Novo Nordisk, Boehringer Ingelheim, Herbalife, WW Int'l, Medtronic and More | GLP-1 Drugs, Oral Therapies, Coverage, and Telehealth Propel Market to $244 Billion by 2036
    GlobeNewswire 2d ago
    European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading

    European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading
    PREMIUM
    MT Newswires 2d ago
    VKTX: Is a 2029 Launch for Its Obesity Drug Within Reach?

    VKTX: Is a 2029 Launch for Its Obesity Drug Within Reach?
    Zacks 2d ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: